, Tracking Stock Market Picks
Enter Symbol:
Pharmacyclics, Inc. (PCYC) [hlAlert]

Sector Perform

Pharmacyclics, Inc. (PCYC) downgraded to Sector Perform with price target $95 by RBC Capital Mkts

Posted on: Tuesday,  May 27, 2014  12:00 AM ET by RBC Capital Mkts

Pharmacyclics, Inc. (NASDAQ: PCYC) downgraded
to Sector Perform with price target $95 by RBC Capital Mkts.

Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/27/2014 12:00 AM Hold
as of 12/13/2013
1 Week down  -15.52 %
1 Month down  -12.87 %
3 Months down  -7.47 %
1 YTD up  86.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/21/2012 12:25 PM Buy
25.40 34.00
12/9/2011 12:25 PM Hold
12.33 15.00
6/20/2011 9:25 AM Buy
9.45 15.00
9/3/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy